Biotech

All Articles

A better consider Fierce Biotech's Strong 15

.Within this full week's episode of "The Top Line," our company are actually diving into Intense Bio...

Lilly deals with period 2 breakdown of tau-targeting med

.The confetti is actually still flying coming from Eli Lilly's event commemorating the commendation ...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant leadership hirings, firings as we...

Lykos will definitely ask FDA to reevaluate its own selection observing turndown of MDMA therapy for post-traumatic stress disorder

.Following a poor presenting for Lykos Rehabs' MDMA prospect for post-traumatic stress disorder at a...

AN 2 fifty percents roll call, ceases phase 3 test after information let down

.AN2 Therapeutics is rethinking its business in reaction to lackluster midphase data, vowing to lay ...

Merck spends $700M for bispecific, spying autoimmune position and opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 million beforehand to test Amgen in a blood stream cance...

Gilead spends J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its liver illness drug seladelpar, the busin...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks can view the companies setting up tents at basecamp behind Eli ...

Entero laying off workers, moving out of office and also stopping briefly R&ampD

.Bed Liquidators has actually transformed Entero Rehabs white as a piece. The creditor ordered Enter...

Exelixis drops ADC after choosing it's no match for Tivdak

.Exelixis is actually quiting on its own tissue factor (TF)- targeting antibody-drug conjugate after...